Trident Texofab Limited has announced the outcome of its Board Meeting held on November 5, 2026. The Board approved and took on record the unaudited standalone financial results for the quarter and half year ended September 30, 2026, along with the Limited Review Report. The company also took note of various compliances made during the quarter.
Trident Texofab Board Approves Q2 FY27 Financials
Trident Texofab Limited announced on November 5, 2026, that its Board of Directors met and approved the unaudited standalone financial results for the quarter and half-year ended September 30, 2026. These results were prepared in accordance with applicable accounting standards and have been taken on record by the Board.
Limited Review Report and Compliance
Accompanying the financial results is a Limited Review Report issued by the Statutory Auditor, A Bafna & Associates. The company has also uploaded the financial results and the review report on its official website, www.tridenttexofab.com. Additionally, the Board took note of various compliances undertaken during the specified period. The meeting commenced at 07:00 PM and concluded at 07:45 PM on November 5, 2026.
Financial Snapshot
The Statement of Assets and Liabilities as at September 30, 2026, shows total assets of ₹11,738.04 Lakhs, with equity and liabilities totaling the same amount. For the quarter ended September 30, 2026, the company reported a profit after tax of ₹60.40 Lakhs. The Statement of Profit and Loss for the half year ended September 30, 2026, indicates a profit after tax from continuing operations of ₹112.57 Lakhs.
Source: BSE
